✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹1,33,402 Cr.
P/E
31.00
About
Cipla Limited, a global pharmaceutical company established in 1935, is dedicated to providing affordable medicines to those in need. The company manufactures, develops, and markets a wide range of bra… Read more
Cipla Limited, a global pharmaceutical company established in 1935, is dedicated to providing … Read more
Low
1132
52W Range
High
1683
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Custom financial statement
Edit rows
Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
1.36 %
(as of Jul 22)
Anti - Diabetes - Market Share
7.76 %
(as of Jul 22)
Anti-Infectives - Market Share
0.96 %
(as of Nov 21)
Anti-Malarial - Market Share
5.93 %
(as of Nov 21)
Antineo Plastic - Market Share
0.79 %
(as of Nov 21)
Blood Related - Market Share
4.48 %
(as of Jul 22)
Cardiovascular - Market Share
Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Global API

Location Wise Break-Up

Therapeutic Area Break-Up - Global API

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    Select a Metric
    • US DMF Filings (.)
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Bronco cough syrup
    Coryx
    Suppliers
    • Bharat Dynamics Ltd.
    • Laurus Labs Ltd.
    • Atul Ltd.
    • Aarti Industries Ltd.
    • Ion Exchange (India) Ltd.
    FAQs on Cipla Ltd. Business

    Cipla Limited is a global pharmaceutical company founded in 1935, dedicated to providing affordable medicines worldwide. It offers a broad portfolio of branded and generic formulations and APIs across multiple therapeutic segments.

    Cipla major competitors are Torrent Pharma, Zydus Lifesciences, Dr. Reddy's Lab, Lupin, Mankind Pharma, Aurobindo Pharma, Alkem Laboratories.
    Market Cap of Cipla is ₹1,34,028 Crs.
    While the median market cap of its peers are ₹1,02,734 Crs.

    Cipla seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Sep Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis